- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02376959
Effect of Spiritist "Passe" Energy Therapy in Reducing Anxiety in Volunteers
Study Overview
Detailed Description
The use of complementary medicine has increased significantly worldwide and up to 40% of American patients use some form of complementary therapy[1,2 ]. Among these are the energy therapies such as Reiki[3], Johrei, and Spiritist "passe"[4]. These therapies are based on the modification of the energy fields that surround and penetrate the human body, and are supposedly involved in the health and disease process. Application of these therapies involves touch or laying hands on these energy fields, the existence of which has not yet been proven. Experimental studies have shown the action of energy therapies in animal models or in cell cultures[5,6,4]. Johrei proved to be effective in improving sleep in mice subjected to sleep interruption[5] and in reducing tumor cell growth in vitro[6]. An experimental study was recently published showing the effect of Spiritist "passe" on the growth of bacterial colonies of Escherichia coli. When "passe" was applied with the intention of reducing the growth of colonies there was a statistically significant reduction compared to the control group, subjected to laying of the hands without application of "passe" [4]. This study is recognized as the first experimental evidence of "passe" which is widespread in spiritism. Spiritism is a very common religion and philosophy in Brazil and the use of Spiritist "passe" is a form of treatment under this religion that is highly established in the treatment of psychiatric disorders[7,8]. Therapies used in spiritualism include Spiritist "passe," spiritist education, disobsession, and fluidic water. Studies investigating the scientific basis of these therapies are beginning to feature in the literature[8,9,10]. For energy therapies with clinical purposes, a few meta-analysis studies have evaluated distance healing and some touch therapies without reaching conclusive results, indicating a high heterogeneity between studies and presenting the need for more primary studies in the field[11,12]. Among the energy therapies, Reiki is the most widely studied; however, in recent meta-analysis, due to the large variability of the studies, different endpoints (anxiety, pain, depression) and methodological flaws, its efficacy has not yet been confirmed[13]. However, a more recent systematic review shows the efficacy of Reiki in reducing anxiety and pain[14].
Thus, despite the heterogeneity of the studies, energy therapies appear to have positive effects, particularly on the reduction of anxiety and pain. Spiritist "passe" is an important therapy in Brazil that is similar to other energy therapies such as Reiki and Johrei, and its efficacy has been experimentally confirmed[4]. Therefore, studies on clinical outcomes of this important form of complementary therapy are necessary. Unlike Reiki[14] and Johrei[15], there are no clinical studies on Spiritist "passe" despite its similar basis as an energy therapy.
1. STUDY HYPOTHESIS
The hypothesis of the study is that the Spiritist "passe" energy therapy will result in the reduction of anxiety, depressive symptoms, and improved quality of life in subjects with anxiety. The primary objective is to evaluate the Spiritist "passe" therapy in reducing anxiety in subjects with symptoms of anxiety after 8 weeks of study.
II. OBJECTIVES
PRIMARY OBJECTIVE
The primary objective is to evaluate the efficacy of the Spiritist "passe" therapy in reducing anxiety after 8 weeks of study in subjects with symptoms of anxiety.
SECONDARY OBJECTIVES
- Evaluate the impact of "passe" in reducing depressive symptoms
- Evaluate the impact of "passe" on improving of quality of life
- Evaluate the impact of "passe" on brain wave patterns detected with the electroencephalogram (EEG) III. PATIENTS AND METHODS
1. PATIENTS
1.1. Cohort:
Sixty patients with anxiety, who have not been treated by psychologists or doctors previously and do not use specific medication, will be evaluated. Patients will be recruited through the Botucatu Faculty of Medicine Press Service that will advertise phone numbers in newspapers and magazines and on the radio. Patients will be selected by the researchers according to the inclusion and exclusion criteria.
1.2. Outline: This is a randomized controlled prospective single-center study to evaluate the effect of Spiritist "passe" in reducing anxiety.
The trial will be conducted at a single location in the Clinical Hospital of the Botucatu Faculty of Medicine - UNESP.
Eligible patients who agree to participate and sign the informed consent form will be included in the study. The following four standardized questionnaires will then be administered:
- DUREL questionnaire for assessment of spirituality
- Beck Depression Inventory
- State-Trait Anxiety Inventory (STAI)
- WHOQOL-BREF quality of life questionnaire The questionnaires will be administered by an examiner who will read out the questions and write down the answers. The anxiety questionnaire (STAI) will always be administered first followed by the other questionnaires in random order.
After the questionnaires have been administered, patients will be randomly categorized into two groups, control and treatment (application of Spiritist "passe"), weekly according to the description of the study design.
1.3. Period: The study will begin after approval by the Research Ethics Committee of the Botucatu Faculty of Medicine. Thereafter, patients selected through interviews will be considered eligible if they meet the inclusion and exclusion criteria (described below in section 1.5). Eligible patients will be followed over an 8-week period with weekly applications of the treatment (Spiritist "passe") or the placebo (simulation of Spiritist "passe").
The standardized questionnaires will be administered three times (start, 4 weeks, and 8 weeks). Three assessments by electroencephalogram (start, 4 weeks, and 8 weeks) will also be made.
1.4. Sample: The sample will consist of 60 patients selected by interview following the inclusion and exclusion criteria. Based on the doctoral work of Ricardo Monezzi, the application of Reiki in elderly volunteers with stress resulted in a 20% reduction of anxiety level in the placebo group and 60% in the treatment group. Considering the reduction of anxiety in the control and treatment groups with an alpha of 0.05 and a beta of 0.8, respectively, a sample of 46 patients is planned. Assuming a 25% loss in follow-up, a sample of 60 patients is finalized.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Luis Gustavo M Andrade, Dr.
- Phone Number: 55 14 3814-2574
- Email: landrade@fmb.unesp.br
Study Contact Backup
- Name: Vanessa B Banin, Dr.
- Phone Number: 55 14 3811-6005
- Email: vanessa_banin@yahoo.com.br
Study Locations
-
-
Sao Paulo
-
Botucatu, Sao Paulo, Brazil, 18618970
- Recruiting
- Botucatu Medical School
-
Contact:
- Luis Gustavo M Andrade, Dr.
- Phone Number: 55 14 3811-6547
- Email: landrade@fmb.unesp.br
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age greater ≥18 years
- Score of STAI-Trait questionnaire >41 (corresponding to the 51% for the Brazilian population)
Exclusion Criteria:
- Patients with cognitive impairment who are unable to understand the questionnaires
- Patients undergoing treatment for anxiety or depression
- Patients undergoing psychological counseling
- Patients receiving psychiatric care
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control Group
Application of 8 spiritist "passe" simulation sessions by people without spiritist training at the same time and in the same environment as the treatment group.
|
|
Active Comparator: Treatment Group (Spiritist "passe")
Application of 8 sessions of spiritist "passe" by spiritists with more than 2 years of experience in controlled environments for the same period as the control group.
|
For a period of 5 min per week, the volunteers will remain in the supine position with their eyes closed, in a quiet environment with controlled light and temperature. The applied intervention will consist of placing both hands in the classic Spiritist "passe" position for the stipulated 5-min period. Spiritist "passe" will be applied by volunteers with training and experience of more than two years with the technique. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Anxiety questionnaire from baselaine at 8 weeks
Time Frame: Baselaine; 4 weeks and 8 weeks
|
Baselaine; 4 weeks and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Beck Depression Inventory from baselaine at 8 weeks
Time Frame: Baselaine; 4 weeks and 8 weeks
|
Baselaine; 4 weeks and 8 weeks
|
Change in WHOQOL-BREF quality of life questionnaire from baselaine at 8 weeks
Time Frame: Baselaine; 4 weeks and 8 weeks
|
Baselaine; 4 weeks and 8 weeks
|
Change in DUREL questionnaire for assessment of spirituality from baselaine at 8 weeks
Time Frame: Baselaine; 4 weeks and 8 weeks
|
Baselaine; 4 weeks and 8 weeks
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 31078414.5.0000.5411
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Disorders
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Loma Linda UniversityCompletedParental/Caregiver Anxiety | Child's AnxietyUnited States
-
Institut National de la Santé Et de la Recherche...UnknownAnxiety Disorders | Anxiety | Anxiety and FearFrance
Clinical Trials on Spiritist "passe"
-
Federal University of Juiz de ForaUnknownKnee OsteoarthritisBrazil
-
Universidade Federal do Triangulo MineiroRecruiting
-
Universidade Federal do Triangulo MineiroRecruitingDepression | Pain | Stress | Anxiety | Well-beingBrazil
-
Universidade Federal do Triangulo MineiroCompleted
-
Universidade Federal do Triangulo MineiroRecruiting